GSK690
GSK690 Basic information
- Product Name:
- GSK690
- Synonyms:
-
- GSK690
- Benzonitrile, 4-[2-(4-methylphenyl)-5-[(3R)-3-pyrrolidinylmethoxy]-3-pyridinyl]-
- CAS:
- 2101305-84-2
- MF:
- C24H23N3O
- MW:
- 369.46
- Mol File:
- 2101305-84-2.mol
More
Less
GSK690 Chemical Properties
- Boiling point:
- 530.5±50.0 °C(Predicted)
- Density
- 1.21±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: 2mg/mL, clear
- pka
- 9.91±0.10(Predicted)
- form
- powder
- color
- white to beige
- InChI
- 1S/C24H23N3O/c1-17-2-6-21(7-3-17)24-23(20-8-4-18(13-25)5-9-20)12-22(15-27-24)28-16-19-10-11-26-14-19/h2-9,12,15,19,26H,10-11,14,16H2,1H3/t19-/m1/s1
- InChIKey
- IQVDLEXWAPYWDT-LJQANCHMSA-N
- SMILES
- N#CC1=CC=C(C2=CC(OC[C@H]3CNCC3)=CN=C2C4=CC=C(C)C=C4)C=C1
More
Less
GSK690 Usage And Synthesis
Description
GSK-690 is a potent and selective Reversible Inhibitors of Lysine Specific Demethylase 1.
Uses
GSK 690 is a reversible inhibitor of lysine specific demethylase 1 (LSD1), with a Kd value of 9 nM and a biochemical IC50 of 37 nM.
References
[1] Mould DP, et al. Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1. J Med Chem. 2017 Oct 12;60(19):7984-7999. DOI:10.1021/acs.jmedchem.7b00462
[2] Haydn T, et al. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells. Cell Death Dis. 2017 Jun 15;8(6):e2879. DOI:10.1038/cddis.2017.239
GSK690Supplier
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai Chaolan Chemical Technology Center
- Tel
- 021-QQ:65489617 15618227136
- Sales@ATKchemical.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
InvivoChem
- Tel
- +1-708-310-1919 +1-13798911105
- sales@invivochem.cn
Suzhou Chenrui Biotechnology Co. LTD
- Tel
- 17625585511
- 1580084073@qq.com